Fusion Returns to Profitability, Asset Quality & Collection Efficiency, and Growth momentum strengthened in Q4FY26May 18, 2026
Cupid Limited Surpasses FY26 Guidance With Record Revenue Growth of 93 Percent YoY and Net Profit Growth of 165 Percent YoYMay 18, 2026
Fredun Pharmaceuticals Limited Announces Strategic Launch of “HORMONE RANGE PRODUCTS,” A Premium Longevity and Human Performance Therapeutics BrandMay 18, 2026
Business Fredun Pharmaceuticals Limited Announces Strategic Launch of “HORMONE RANGE PRODUCTS,” A Premium Longevity and Human Performance Therapeutics BrandMay 18, 2026 Mumbai (Maharashtra) [India], May 18: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730) is pleased to…
